Amgen bone drug gets NICE thumbs up

It's another victory for Amgen with its new drug Prolia. The U.K.'s cost-effectiveness watchdog has recommended use of the bone treatment by the National Health Service, in women at risk of fractures who can't take existing drugs. Report